The weekly litigation news digest is live. Subscribe now

IP Verse

Crystalline Dapagliflozin Hydrate - EP2785702

The patent EP2785702 was granted to Sandoz on Jan 22, 2020. The application was originally filed on Nov 28, 2012 under application number EP12791764A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2785702

SANDOZ
Application Number
EP12791764A
Filing Date
Nov 28, 2012
Status
Opposition Rejected
Apr 27, 2024
Publication Date
Jan 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UK TRADING MYLANOct 22, 2020GILL JENNINGS & EVERYADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO03099836
DESCRIPTIONWO2008002824
DESCRIPTIONWO2008116179
INTERNATIONAL-SEARCH-REPORTWO2008002824
OPPOSITIONWO2007028814
OPPOSITIONWO2008002824

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents